Advertisement
U.S. markets open in 3 hours 34 minutes

Ascendis Pharma A/S (ASND)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
147.06-1.64 (-1.10%)
At close: 04:00PM EDT
147.06 0.00 (0.00%)
After hours: 05:39PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
8.33B7.13B5.29B5.02B6.03B6.96B
Enterprise Value
8.59B7.36B5.37B4.77B5.78B6.57B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
28.4842.0641.6858.92107.74194.43
Price/Book (mrq)
N/AN/A77.3127.6220.9914.50
Enterprise Value/Revenue
32.2253.46111.87100.67172.07287.12
Enterprise Value/EBITDA
-20.90-108.75-40.61-44.22-60.69-34.22

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 335.02%
S&P500 52-Week Change 328.64%
52 Week High 3161.00
52 Week Low 364.33
50-Day Moving Average 3143.13
200-Day Moving Average 3108.03

Share Statistics

Avg Vol (3 month) 3400.51k
Avg Vol (10 day) 3240.56k
Shares Outstanding 556.61M
Implied Shares Outstanding 656.61M
Float 856.16M
% Held by Insiders 10.76%
% Held by Institutions 1107.68%
Shares Short (Feb 29, 2024) 43M
Short Ratio (Feb 29, 2024) 46.65
Short % of Float (Feb 29, 2024) 47.63%
Short % of Shares Outstanding (Feb 29, 2024) 45.29%
Shares Short (prior month Jan 31, 2024) 42.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -180.51%
Operating Margin (ttm)-26.59%

Management Effectiveness

Return on Assets (ttm)-29.73%
Return on Equity (ttm)-818.43%

Income Statement

Revenue (ttm)266.72M
Revenue Per Share (ttm)4.74
Quarterly Revenue Growth (yoy)501.40%
Gross Profit (ttm)N/A
EBITDA -448.99M
Net Income Avi to Common (ttm)-481.45M
Diluted EPS (ttm)-9.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)399.44M
Total Cash Per Share (mrq)7.05
Total Debt (mrq)644.27M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.56
Book Value Per Share (mrq)-2.57

Cash Flow Statement

Operating Cash Flow (ttm)-467.36M
Levered Free Cash Flow (ttm)-318.3M